1 active not recruiting, 1 completed, 1 recruiting, 1 terminated. 5 Phase 2, 2 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Active not recruiting 1, Completed 1, Recruiting 1, Terminated 1, Unknown 1 |
| Phase 3 | 2 | Completed 1, Unknown 1 |
| Phase 1 | 1 | Recruiting 1 |
Follow Sickle Cell Anemia in Children: new trials by email Literature Review of Sickle Cell Anemia in Children trials Research Report on Sickle Cell Anemia in Children
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Optimizing Hydroxyurea Therapy in Children With Sickle Cell Anemia In Malaria Endemic Areas: The NOHARM Maximum Tolerated Dose (MTD) Study hydroxycarbamide - Sickle Cell Disease, Sickle Cell Anemia in Children | Phase 1 / Phase 2 | Recruiting | Children's Hospital Medical Center, Cincinnati | 250 | 2026-05-13 | 2026-07-16 |
| The Effect of Voxelotor on Cerebral Hemodynamic Response in Children With Sickle Cell Anemia Voxelotor - Sickle Cell Anemia in Children | Phase 2 | Terminated | Emory University | 22 | 2022-03-28 | 2025-12-12 |
| Gum Arabic as Anti-oxidant, Anti-inflammatory and Fetal Hemoglobin Inducing Agent in Sickle Cell Anemia Patients Acacia Senegal extract, Pectin - Sickle Cell Anemia in Children | Phase 2 / Phase 3 | Unknown | Al-Neelain University | 100 | 2020-02-15 | 2020-01-28 |
| Different Treatment Modalities in the Management of the Painful Crisis in Pediatric Sickle- Cell Anemia Omega 3, Vit D, Zinc sulfate - Vaso-occlusive Crisis, Sickle Cell Disease | Phase 2 / Phase 3 | Completed | Beni-Suef University | 350 | 2019-11-01 | 2021-01-27 |
| Stroke Prevention With Hydroxyurea Enabled Through Research and Education (SPHERE) Hydroxyurea, Elevated Arm TCD Examination, Normal Arm TCD Examination - Sickle Cell Anemia in Children | Phase 2 | Active not recruiting | Children's Hospital Medical Center, Cincinnati | 202 | 2019-04-24 | 2026-10-19 |
Anemia, Sickle Cell (3) · Stroke (1) · Vaso-Occlusive Crises (1) · beta-Thalassemia (1)
Anemia (3) · Anemia, Hemolytic (3) · Anemia, Hemolytic, Congenital (3) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3) · Genetic Diseases, Inborn (3) · Hematologic Diseases (3) · Hemic and Lymphatic Diseases (3) · Hemoglobinopathies (3) · Brain Diseases (1) · Cardiovascular Diseases (1) · Central Nervous System Diseases (1) · Cerebrovascular Disorders (1) · Nervous System Diseases (1) · Thalassemia (1) · Vascular Diseases (1)
Hydroxyurea (3) · Cardiovascular Agents (1) · Docosahexaenoic Acids (1) · Gum Arabic (1) · Hydroxymethylglutaryl-CoA Reductase Inhibitors (1) · Morphine (1) · Pectins (1) · Simvastatin (1) · Zinc Sulfate (1) · voxelotor (1)
Children's Hospital Medical Center, Cincinnati (2) · Al-Neelain University (1) · Beni-Suef University (1) · Emory University (1)
United States (2) · Egypt (1) · Saudi Arabia (1) · Sudan (1) · Tanzania (1) · Uganda (1)
Ahmed F Mahmoud Hussein, MS.c (1) · Amy Tang, MD (1) · Imad M Fdl-Elmula, PhD (1) · Russell E. Ware, MD, PhD (1)